secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclo Therapeutics, Inc. (—)
CIK:        0000922247
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001437749-23-015116
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclo Therapeutics receives Nasdaq delisting notice for negative equity
-----------------------------------------------------------------------

- Stockholders' equity of -$438,876 as of Mar 31, 2023, below Nasdaq's $2.5M minimum.
- Company has until June 29, 2023 to submit a compliance plan to Nasdaq.
- If plan is accepted, Nasdaq may grant an extension of up to 180 days to regain compliance.
- Failure could lead to suspension or delisting, with right to a hearing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/922247/000143774923015116/0001437749-23-015116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/922247/000143774923015116/ctdh20230518_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-015116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer